Jupiter Neurosciences (JUNS) grants 536,428 stock options to board director

Q: What did JUNS director Tomas Jan Philipson receive in this Form 4?

He received a grant of 536,428 stock options , each representing the right to purchase one share of common stock at $0.21 per share . These options are part of his board compensation package rather than an open-market purchase.

Q: How is the 536,428-option grant for JUNS director Philipson structured?

The grant includes 90,000 options tied to his appointment to the Board and 446,428 options granted in lieu of cash board retainer and committee fees. All options share the same $0.21 exercise price and vesting schedule.

Q: When do Tomas Jan Philipson’s JUNS stock options vest?

The options vest in 12 equal quarterly installments , starting on September 2, 2026 . Vesting is subject to his continued service as a director through each vesting date, meaning he must remain on the board for options to continue vesting.

Q: What is the exercise price and expiration for JUNS options granted to Philipson?

Each option has an exercise price of $0.21 per share and is scheduled to expire on June 29, 2036 . This defines the cost to convert each option into common stock and the final date by which exercises can occur.

Q: Are the JUNS options granted to Philipson part of an equity plan?

Yes. The 536,428 stock options were granted under the company’s 2025 Equity Incentive Plan . This plan governs equity-based compensation for eligible participants, including directors, and sets terms for grants, vesting, and other conditions.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

JUPITER NEUROSCIENCES, INC. director Tomas Jan Philipson received a grant of stock options as board compensation. He was awarded 536,428 stock options, each for one share of common stock at an exercise price of $0.21 per share. Of this grant, 90,000 options relate to his appointment to the Board of Directors, and 446,428 options were granted instead of cash for his annual board retainer and committee fees. The options vest in 12 equal quarterly installments beginning on September 2, 2026, as long as he continues to serve as a director through each vesting date, and are scheduled to expire on June 29, 2036.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Philipson Tomas Jan

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	536,428	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 536,428 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Options granted: 536,428 options Exercise price: $0.21 per share Appointment-related options: 90,000 options +3 more

6 metrics

Options granted 536,428 options Stock option grant to director

Exercise price $0.21 per share Stock option exercise price

Appointment-related options 90,000 options Granted for Board of Directors appointment

Options in lieu of cash 446,428 options In lieu of annual board retainer and committee fees

Vesting schedule 12 quarterly installments Beginning September 2, 2026

Expiration date June 29, 2036 Option expiration

Key Terms

stock options, 2025 Equity Incentive Plan, annual board retainer, vesting

4 terms

stock options financial

"Represents a grant of 536,428 stock options (each representing the right to purchase one share of Common Stock)"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

2025 Equity Incentive Plan financial

"under the Issuer's 2025 Equity Incentive Plan"

annual board retainer financial

"granted in lieu of cash compensation otherwise payable as an annual board retainer and committee fees"

vesting financial

"The options vest in 12 equal quarterly installments beginning September 2, 2026"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 04:02 PM Accepted by SEC EDGAR 07/01/2026 - 04:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Philipson Tomas Jan

(Last)

(First)

(Middle)

C/O JUPITER NEUROSCIENCES, INC.

1001 NORTH US HYWAY 1, SUITE 504

(Street)

JUPITER

FLORIDA

33477

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$0.21	06/29/2026		A		536,428		⁽¹⁾	06/29/2036	Common Stock	536,428	$0	536,428	D

Explanation of Responses:

1. Represents a grant of 536,428 stock options (each representing the right to purchase one share of Common Stock) under the Issuer's 2025 Equity Incentive Plan. Of this amount, 90,000 options were granted in connection with the Reporting Person's appointment to the Board of Directors and 446,428 options were granted in lieu of cash compensation otherwise payable as an annual board retainer and committee fees. The options vest in 12 equal quarterly installments beginning September 2, 2026, subject to the Reporting Person's continued service as a director through each vesting date.

	/s/ Tomas J. Philipson	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did JUNS director Tomas Jan Philipson receive in this Form 4?

He received a grant of 536,428 stock options, each representing the right to purchase one share of common stock at $0.21 per share. These options are part of his board compensation package rather than an open-market purchase.

How is the 536,428-option grant for JUNS director Philipson structured?

The grant includes 90,000 options tied to his appointment to the Board and 446,428 options granted in lieu of cash board retainer and committee fees. All options share the same $0.21 exercise price and vesting schedule.

When do Tomas Jan Philipson’s JUNS stock options vest?

The options vest in 12 equal quarterly installments, starting on September 2, 2026. Vesting is subject to his continued service as a director through each vesting date, meaning he must remain on the board for options to continue vesting.

What is the exercise price and expiration for JUNS options granted to Philipson?

Each option has an exercise price of $0.21 per share and is scheduled to expire on June 29, 2036. This defines the cost to convert each option into common stock and the final date by which exercises can occur.

Are the JUNS options granted to Philipson part of an equity plan?

Yes. The 536,428 stock options were granted under the company’s 2025 Equity Incentive Plan. This plan governs equity-based compensation for eligible participants, including directors, and sets terms for grants, vesting, and other conditions.